Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats

Kathirvel Gopalakrishnan, Jay S. Mishra, Vijayakumar Chinnathambi, Kathleen Vincent, Igor Patrikeev, Massoud Motamedi, George Saade, Gary Hankins, Kunju Sathishkumar

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Elevated maternal testosterone levels are shown to cause fetal growth restriction, eventually culminating in sex-specific adult-onset hypertension that is more pronounced in males than in females. In this study, we tested whether uteroplacental and fetoplacental disturbances underlie fetal growth restriction and if these changes vary in male and female placentas. Pregnant Sprague-Dawley rats were injected with vehicle (n=16) or testosterone propionate (0.5 mg/kg per day from gestation day 15-19; n=16). On gestation day 20, we quantified uterine artery blood flow using microultrasound, visualized placental arterial network using x-ray microcomputed tomography, determined fetoplacental hypoxia using pimonidazole and hypoxia-inducible factor-1α, and used Affymetrix array to determine changes in placental expression of genes involved in vascular development. Plasma testosterone levels increased 2-fold in testosterone-injected rats. Placental and fetal weights were lower in rats with elevated testosterone. Uterine artery blood flow was lower, and resistance index was higher in the testosterone group. Radial and spiral artery diameter and length, the number of fetoplacental arterial branches, and umbilical artery diameter were reduced in the testosterone group. In addition, markers of hypoxia in the placentas and fetuses were elevated in the testosterone group. The magnitude of changes in placental vasculature and hypoxia was greater in males than in females and was associated with sex-specific alteration of unique sets of genes involved in angiogenesis and blood vessel morphogenesis. The results demonstrate that elevated testosterone during gestation induces a decrease in uterine arterial blood flow and fetal sex-related uteroplacental vascular changes, which may set the stage for subsequent sex differences in adult-onset diseases.

Original languageEnglish (US)
Pages (from-to)630-639
Number of pages10
JournalHypertension
Volume67
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Testosterone
Arteries
Blood Vessels
Uterine Artery
Fetal Development
Pregnancy
Placenta
Testosterone Propionate
Hypoxia-Inducible Factor 1
X-Ray Microtomography
Fetal Weight
Umbilical Arteries
Radial Artery
Fetal Blood
Morphogenesis
Sex Characteristics
Sprague Dawley Rats
Fetus
Mothers
X-Rays

Keywords

  • hypoxia
  • placenta
  • preeclampsia
  • testosterone
  • vascular resistance

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats. / Gopalakrishnan, Kathirvel; Mishra, Jay S.; Chinnathambi, Vijayakumar; Vincent, Kathleen; Patrikeev, Igor; Motamedi, Massoud; Saade, George; Hankins, Gary; Sathishkumar, Kunju.

In: Hypertension, Vol. 67, No. 3, 01.03.2016, p. 630-639.

Research output: Contribution to journalArticle

Gopalakrishnan, Kathirvel ; Mishra, Jay S. ; Chinnathambi, Vijayakumar ; Vincent, Kathleen ; Patrikeev, Igor ; Motamedi, Massoud ; Saade, George ; Hankins, Gary ; Sathishkumar, Kunju. / Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats. In: Hypertension. 2016 ; Vol. 67, No. 3. pp. 630-639.
@article{17f9615d315c4d1a94108ae269c44236,
title = "Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats",
abstract = "Elevated maternal testosterone levels are shown to cause fetal growth restriction, eventually culminating in sex-specific adult-onset hypertension that is more pronounced in males than in females. In this study, we tested whether uteroplacental and fetoplacental disturbances underlie fetal growth restriction and if these changes vary in male and female placentas. Pregnant Sprague-Dawley rats were injected with vehicle (n=16) or testosterone propionate (0.5 mg/kg per day from gestation day 15-19; n=16). On gestation day 20, we quantified uterine artery blood flow using microultrasound, visualized placental arterial network using x-ray microcomputed tomography, determined fetoplacental hypoxia using pimonidazole and hypoxia-inducible factor-1α, and used Affymetrix array to determine changes in placental expression of genes involved in vascular development. Plasma testosterone levels increased 2-fold in testosterone-injected rats. Placental and fetal weights were lower in rats with elevated testosterone. Uterine artery blood flow was lower, and resistance index was higher in the testosterone group. Radial and spiral artery diameter and length, the number of fetoplacental arterial branches, and umbilical artery diameter were reduced in the testosterone group. In addition, markers of hypoxia in the placentas and fetuses were elevated in the testosterone group. The magnitude of changes in placental vasculature and hypoxia was greater in males than in females and was associated with sex-specific alteration of unique sets of genes involved in angiogenesis and blood vessel morphogenesis. The results demonstrate that elevated testosterone during gestation induces a decrease in uterine arterial blood flow and fetal sex-related uteroplacental vascular changes, which may set the stage for subsequent sex differences in adult-onset diseases.",
keywords = "hypoxia, placenta, preeclampsia, testosterone, vascular resistance",
author = "Kathirvel Gopalakrishnan and Mishra, {Jay S.} and Vijayakumar Chinnathambi and Kathleen Vincent and Igor Patrikeev and Massoud Motamedi and George Saade and Gary Hankins and Kunju Sathishkumar",
year = "2016",
month = "3",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.115.06946",
language = "English (US)",
volume = "67",
pages = "630--639",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats

AU - Gopalakrishnan, Kathirvel

AU - Mishra, Jay S.

AU - Chinnathambi, Vijayakumar

AU - Vincent, Kathleen

AU - Patrikeev, Igor

AU - Motamedi, Massoud

AU - Saade, George

AU - Hankins, Gary

AU - Sathishkumar, Kunju

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Elevated maternal testosterone levels are shown to cause fetal growth restriction, eventually culminating in sex-specific adult-onset hypertension that is more pronounced in males than in females. In this study, we tested whether uteroplacental and fetoplacental disturbances underlie fetal growth restriction and if these changes vary in male and female placentas. Pregnant Sprague-Dawley rats were injected with vehicle (n=16) or testosterone propionate (0.5 mg/kg per day from gestation day 15-19; n=16). On gestation day 20, we quantified uterine artery blood flow using microultrasound, visualized placental arterial network using x-ray microcomputed tomography, determined fetoplacental hypoxia using pimonidazole and hypoxia-inducible factor-1α, and used Affymetrix array to determine changes in placental expression of genes involved in vascular development. Plasma testosterone levels increased 2-fold in testosterone-injected rats. Placental and fetal weights were lower in rats with elevated testosterone. Uterine artery blood flow was lower, and resistance index was higher in the testosterone group. Radial and spiral artery diameter and length, the number of fetoplacental arterial branches, and umbilical artery diameter were reduced in the testosterone group. In addition, markers of hypoxia in the placentas and fetuses were elevated in the testosterone group. The magnitude of changes in placental vasculature and hypoxia was greater in males than in females and was associated with sex-specific alteration of unique sets of genes involved in angiogenesis and blood vessel morphogenesis. The results demonstrate that elevated testosterone during gestation induces a decrease in uterine arterial blood flow and fetal sex-related uteroplacental vascular changes, which may set the stage for subsequent sex differences in adult-onset diseases.

AB - Elevated maternal testosterone levels are shown to cause fetal growth restriction, eventually culminating in sex-specific adult-onset hypertension that is more pronounced in males than in females. In this study, we tested whether uteroplacental and fetoplacental disturbances underlie fetal growth restriction and if these changes vary in male and female placentas. Pregnant Sprague-Dawley rats were injected with vehicle (n=16) or testosterone propionate (0.5 mg/kg per day from gestation day 15-19; n=16). On gestation day 20, we quantified uterine artery blood flow using microultrasound, visualized placental arterial network using x-ray microcomputed tomography, determined fetoplacental hypoxia using pimonidazole and hypoxia-inducible factor-1α, and used Affymetrix array to determine changes in placental expression of genes involved in vascular development. Plasma testosterone levels increased 2-fold in testosterone-injected rats. Placental and fetal weights were lower in rats with elevated testosterone. Uterine artery blood flow was lower, and resistance index was higher in the testosterone group. Radial and spiral artery diameter and length, the number of fetoplacental arterial branches, and umbilical artery diameter were reduced in the testosterone group. In addition, markers of hypoxia in the placentas and fetuses were elevated in the testosterone group. The magnitude of changes in placental vasculature and hypoxia was greater in males than in females and was associated with sex-specific alteration of unique sets of genes involved in angiogenesis and blood vessel morphogenesis. The results demonstrate that elevated testosterone during gestation induces a decrease in uterine arterial blood flow and fetal sex-related uteroplacental vascular changes, which may set the stage for subsequent sex differences in adult-onset diseases.

KW - hypoxia

KW - placenta

KW - preeclampsia

KW - testosterone

KW - vascular resistance

UR - http://www.scopus.com/inward/record.url?scp=84958045988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958045988&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.115.06946

DO - 10.1161/HYPERTENSIONAHA.115.06946

M3 - Article

VL - 67

SP - 630

EP - 639

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3

ER -